Heidelberg, Germany-based research institute BioMed X announced a new collaboration with Denmark’s Novo Nordisk, which aims ...

Privately-held US biotech Skyhawk Therapeutics has announced a strategic research collaboration with Germany’s Merck KGaA ...

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

Australian biotech CSL Limited today reported net profit after tax of US$3.0 billion for the 12 months ended June 30, 2025, ...

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...

Clinical research provider IQVIA and Veeva System have announced global clinical and commercial partnerships and the complete ...

Swedish biotech Anocca has raised about 440 million Swedish kronor ($46 million) in new financing to accelerate development ...

US pharma major Bristol Myers Squibb has appointed Dr Nathan Pennell as senior vice president, worldwide head of medical ...

The European Commission (EC) granted marketing authorization for Ogsiveo (nirogacestat), an oral gamma secretase inhibitor, ...

Vanda Pharmaceuticals (Nasdaq: VNDA) secured a sweeping victory in its legal battle with the US regulator after the Court of Appeals for the District of Columbia Circuit overturned the agency’s ...

A clinical-stage specialty pharma company based in Tel Aviv, Israel, focused on developing needle-free, powder-based ...